The mission of Invitrox, Inc. is to develop specific therapeutic / theranostic cell based assays to run on two distinct laser light scattering platforms. Invitrox utilizes its own proprietary spectrometer technologies that have the flexibility and specificity to fingerprint intact cells and size / count / phenotype microparticles / nanoparticles found in biologic fluids. These proprietary technologies are unique and differentiated from all available existing marketed techniques for cellular analysis.
By advancing its portfolio of clinical assays, Invitrox intends to become a standout “in vitro” diagnostics company, competing initially in the cardiovascular market segment. The Company’s first assays will be optimized for platelet function testing and anti-coagulant drug assessment.